Abstract
New fluorinated 2-aryl-benzothiazoles, -benzoxazoles, and -chromen-4-ones have been synthesized and their
activity against MCF-7 and MDA 468 breast cancer cell lines compared with the potent antitumor
benzothiazole 5. Analogues such as 9a,b and 12a,d yielded submicromolar GI50 values in both cell lines;
however, none of the new compounds approached 5 in terms of antitumor potency. For 5, binding to the
aryl hydrocarbon receptor appeared to be necessary but not sufficient for growth inhibition.
| Original language | English |
|---|---|
| Pages (from-to) | 5135-5139 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 51 |
| Issue number | 16 |
| Early online date | 31 Jul 2008 |
| DOIs | |
| Publication status | Published - 28 Aug 2008 |
Keywords
- Cancer studies